- Home
- MURA vs BODI Comparison
MURA vs BODI Comparison
Compare MURA & BODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MURA
- BODI
- Stock Information
- Founded
- MURA 2013
- BODI 1998
- Country
- MURA Ireland
- BODI United States
- Employees
- MURA N/A
- BODI N/A
- Industry
- MURA
- BODI Industrial Machinery/Components
- Sector
- MURA
- BODI Industrials
- Exchange
- MURA Nasdaq
- BODI Nasdaq
- Market Cap
- MURA 30.7M
- BODI 31.6M
- IPO Year
- MURA N/A
- BODI N/A
- Fundamental
- Price
- MURA $1.82
- BODI $5.65
- Analyst Decision
- MURA Strong Buy
- BODI Buy
- Analyst Count
- MURA 3
- BODI 2
- Target Price
- MURA $12.00
- BODI $10.00
- AVG Volume (30 Days)
- MURA 281.7K
- BODI 29.3K
- Earning Date
- MURA 08-04-2025
- BODI 08-05-2025
- Dividend Yield
- MURA N/A
- BODI N/A
- EPS Growth
- MURA N/A
- BODI N/A
- EPS
- MURA N/A
- BODI N/A
- Revenue
- MURA N/A
- BODI $324,871,000.00
- Revenue This Year
- MURA N/A
- BODI N/A
- Revenue Next Year
- MURA N/A
- BODI N/A
- P/E Ratio
- MURA N/A
- BODI N/A
- Revenue Growth
- MURA N/A
- BODI N/A
- 52 Week Low
- MURA $0.95
- BODI $3.38
- 52 Week High
- MURA $4.74
- BODI $8.71
- Technical
- Relative Strength Index (RSI)
- MURA 36.95
- BODI 72.32
- Support Level
- MURA $1.53
- BODI $4.10
- Resistance Level
- MURA $1.83
- BODI $5.12
- Average True Range (ATR)
- MURA 0.17
- BODI 0.43
- MACD
- MURA -0.01
- BODI 0.12
- Stochastic Oscillator
- MURA 33.33
- BODI 86.30
About MURA Mural Oncology plc
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.
About BODI The Beachbody Company Inc. Class A Common Stock
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.